Boostrix

Pays: Philippines

Langue: anglais

Source: FDA (Food And Drug Administration)

Ingrédients actifs:

Diphtheria-Tetanus Toxoids And Acellular Pertussis Vaccine, Adsorbed

Disponible depuis:

GlaxoSmithKline Philippines, Inc.

DCI (Dénomination commune internationale):

Diphtheria-Tetanus Toxoids And Acellular Pertussis Vaccine, Adsorbed

Dosage:

Formulation: Each dose (0.5 mL) contains: Diphtheria toxoid -2.5LF Tetanus toxoid-5.0 Lf Pertussis toxoid-8 mcg Filamentous hemagglutinin (FHA)-8 mcg Pertactin (PRN or 69 kDa OMP)-2.5 mcg

forme pharmaceutique:

0.5 mL Suspension for Injection (IM) - 2PE (See reverse for Formulation)

Unités en paquet:

0.5 mL Pre-filled Type I Glass Syringe + 2 Sterile Needles [236 x 1” and 256 x 5/8"] (Box of l’s) (Single Dose), 0.5 mL Pre-fi

Fabriqué par:

GlaxoSmithKline Biologicals SA, Belgium

Descriptif du produit:

Formulation: Each dose (0.5 mL) contains: Diphtheria toxoid -2.5LF Tetanus toxoid-5.0 Lf Pertussis toxoid-8 mcg Filamentous hemagglutinin (FHA)-8 mcg Pertactin (PRN or 69 kDa OMP)-2.5 mcg

Date de l'autorisation:

2021-02-19